<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05035693</url>
  </required_header>
  <id_info>
    <org_study_id>P004</org_study_id>
    <secondary_id>DRKS00022971</secondary_id>
    <nct_id>NCT05035693</nct_id>
  </id_info>
  <brief_title>Post Market Clinical Follow up Study With the Cervical Disc Prothesis MOVE®-C</brief_title>
  <acronym>PMCF_MOVE®-C</acronym>
  <official_title>&quot;PMCF MOVE®-C&quot; International, Prospective, Multicentre, Non-randomised Post-market Clinical Follow-up Study Clinical and Radiological Outcome After Mono- and Bisegmental Cervical Intervertebral Disc Prosthetics</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>NGMedical GmbH</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>NGMedical GmbH</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Study design: International, prospective, multicentre, non-randomised, observational study&#xD;
      according to § 23b MPG.&#xD;
&#xD;
      Objectives: Observational study to confirm the safety and performance of the cervical disc&#xD;
      prosthesis MOVE®-C.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This clinical investigation is conducted to gain post market results on the Cervical Disc&#xD;
      Prosthesis MOVE®-C and to demonstrate the safety and performance. Besides, it is aimed to&#xD;
      gain knowledge concerning the development of patients' quality of life (QoL) after the&#xD;
      implantation of the Cervical Disc Prosthesis MOVE®-C and to collect data for the analysis of&#xD;
      the range of motion (ROM), which is an essential parameter for motion-preserving implants.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 11, 2021</start_date>
  <completion_date type="Anticipated">March 11, 2025</completion_date>
  <primary_completion_date type="Anticipated">March 11, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Improvement from baseline on Neck Disability Index (NDI)</measure>
    <time_frame>Baseline and month 24</time_frame>
    <description>Primary outcome measure 1 and 2 are combined endpoints. Improvement of the NDI of more than 15 points for a change (pre-postoperative) of up to 30 points with a standard deviation of 25 points.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Improvement from baseline on Visual Analogue Scales (VAS arm/neck)</measure>
    <time_frame>Baseline and month 24</time_frame>
    <description>Primary outcome measure 1 and 2 are combined endpoints. Improvement of arm and neck pain scale (VAS arm/neck) of more than 2 points at a change (pre-postoperative) of 2.7 points with a standard deviation of 2.5 points.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in Core Outcome Measure Index (COMI neck)</measure>
    <time_frame>Baseline and months 24</time_frame>
    <description>The clinical results of COMI neck will be compared to the 24 months visit before the operation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in Short Form 36 Health Survey Questionnaire (SF-36)</measure>
    <time_frame>Baseline and moths 24</time_frame>
    <description>The clinical results of SF-36 will be compared to the 24 months visit before the operation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in EuroQoL (EQ-5D-5L)</measure>
    <time_frame>Baseline and moths 24</time_frame>
    <description>The clinical results of (EQ-5D-5L) will be compared to the 24 months visit before the operation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in Japanese Orthopedic Association Score (JOA)</measure>
    <time_frame>Baseline and moths 24</time_frame>
    <description>The clinical results of (JOA) will be compared to the 24 months visit before the operation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Analyse of the Range of Motion (ROM)</measure>
    <time_frame>Baseline and moths 24</time_frame>
    <description>The radiological results of the ROM are compared to the 24 months visit before the operation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Monitoring of product related occurence of adverse events (AE-Monitoring)</measure>
    <time_frame>Baseline and moths 24</time_frame>
    <description>The radiological results of the AE-Monitoring are compared to the 24 months visit before the operation.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">170</enrollment>
  <condition>Discopathy</condition>
  <condition>Herniated Cervical Disc</condition>
  <condition>Stenoses, Spinal</condition>
  <condition>Radiculopathy</condition>
  <arm_group>
    <arm_group_label>PMCF MOVE-C</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>PMCF MOVE®_C is a single arm observational study with 170 patients.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MOVE®-C</intervention_name>
    <description>Momo- or bisegmental implantation of MOVE®-C cervical prothesis.</description>
    <arm_group_label>PMCF MOVE-C</arm_group_label>
    <other_name>cervical disc prothesis</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Diagnosis of discopathy or disc hernia with radiculopathy or stenosis of the foramen&#xD;
             and spinal canal,&#xD;
&#xD;
          2. documented individual history of neck and/or upper extremity pain and/or&#xD;
             functional/neurological deficit associated with the cervical level to be treated,&#xD;
&#xD;
          3. no surgical treatment regarding the planned index surgery within the last six weeks&#xD;
             prior implantation,&#xD;
&#xD;
          4. unsuccessful conservative medical care regarding the indication within the last six&#xD;
             weeks,&#xD;
&#xD;
          5. age ≥18 years,&#xD;
&#xD;
          6. patient must agree to fully participate in the clinical trial and give informed&#xD;
             consent in writing,&#xD;
&#xD;
          7. patient is capable to realise the nature, aims and possible consequences of the&#xD;
             clinical trial (MPG §20.2.1),&#xD;
&#xD;
          8. patient information has been provided and all written consents of the patient are&#xD;
             available.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Known contraindication against the use of cervical intervertebral disc prostheses in&#xD;
             accordance with the manufacturer's instructions for use:&#xD;
&#xD;
               1. Bone mineral density with T-score ≤ -1.5 as determined by spine DXA if male ≥ 60&#xD;
                  years of age or female ≥ 50 years of age,&#xD;
&#xD;
               2. active systemic infection or infection at the operative site,&#xD;
&#xD;
               3. sustained osteoporotic fracture of the spine, hip or wrist,&#xD;
&#xD;
               4. spinal metastases,&#xD;
&#xD;
               5. known allergy to titanium or polycarbonate-urethane,&#xD;
&#xD;
               6. confirmed pregnancy,&#xD;
&#xD;
               7. severe cervical myelopathy,&#xD;
&#xD;
               8. patients requiring a treatment that destabilises the spine (e.g. posterior&#xD;
                  element decompression),&#xD;
&#xD;
               9. advanced cervical anatomical deformity at the operative site (e.g. ankylosing&#xD;
                  spondylitis, scoliosis),&#xD;
&#xD;
              10. advanced degenerative changes (e.g. spondylosis) at the index vertebral level,&#xD;
&#xD;
              11. patient is kept in an institution under judicial or official orders (MPG §20.3).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Olaf Süss, PD Dr. med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>DRK Kliniken Berlin</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Saskia Mathieu, M.Sc.</last_name>
    <phone>+49687399997118</phone>
    <email>smathieu@ngmedical.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Nino Weiland, B.Sc.</last_name>
    <phone>+49687399997104</phone>
    <email>nweiland@ngmedical.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Klinik Penzing</name>
      <address>
        <city>Wien</city>
        <zip>1180</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ronald Sabitzer, OA</last_name>
      <phone>0043 6767017974</phone>
      <email>ronald.sabitzer@gesundheitsverbund.de</email>
    </contact>
    <contact_backup>
      <last_name>Dagmar Leitner</last_name>
    </contact_backup>
    <investigator>
      <last_name>Nadja Jerisch</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rhein-Maas Klinikum</name>
      <address>
        <city>Würselen</city>
        <state>Aachen</state>
        <zip>52146</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Rolf Sobottke, Prof.Dr.med.</last_name>
      <phone>0049 2405623372</phone>
      <email>rolf.sobottke@rheinmaasklinikum.de</email>
    </contact>
    <contact_backup>
      <last_name>Marianne Hornbach</last_name>
      <phone>0049 2405623372</phone>
    </contact_backup>
    <investigator>
      <last_name>Khaled Allan</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Katholisches Klinikum Koblenz - Montabaur</name>
      <address>
        <city>Koblenz</city>
        <state>Rheinland-pfalz</state>
        <zip>56073</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francis K Kilian, Dr.med.</last_name>
      <phone>0049 261 496-6457</phone>
      <email>f.kilian@kk-km.de</email>
    </contact>
    <contact_backup>
      <last_name>Nina Schroeder</last_name>
      <phone>0049 261 496-6457</phone>
      <email>n.schroeder@kk-km.de</email>
    </contact_backup>
    <investigator>
      <last_name>Bernhard Bruchmann, Dr.med.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>DRK Klinikum Berlin</name>
      <address>
        <city>Berlin</city>
        <zip>14050</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olaf Süss, PD Dr.med.</last_name>
      <phone>+493030354260</phone>
      <email>olaf.suess@drk-kliniken.de</email>
    </contact>
    <contact_backup>
      <last_name>Sven Mularski, Dr.med.</last_name>
      <phone>+493030354260</phone>
      <email>sven.mularski@drk-kliniken.de</email>
    </contact_backup>
    <investigator>
      <last_name>Björn Kühn, Dr. med.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Thomas Langer, Dr.med</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Stätisches Klinikum Karlsruhe gGmbH</name>
      <address>
        <city>Karlsruhe</city>
        <zip>76133</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>George Kiriyanthan, Dr. med.</last_name>
      <phone>+49072197463521</phone>
      <email>george.kiriyanthan@klinikum-karlsruhe.de</email>
    </contact>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Germany</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>March 12, 2021</study_first_submitted>
  <study_first_submitted_qc>August 31, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 5, 2021</study_first_posted>
  <last_update_submitted>September 10, 2021</last_update_submitted>
  <last_update_submitted_qc>September 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 17, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Herniated Disc</keyword>
  <keyword>Cervical Spine</keyword>
  <keyword>Discopathy</keyword>
  <keyword>Radiculopathy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spinal Stenosis</mesh_term>
    <mesh_term>Radiculopathy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>No IPD will be available for other researchers, that will not be a study site in this clinical trial.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

